PLZF Expression during Colorectal Cancer Development and  in Normal Colorectal Mucosa according to Body Size, as Marker of Colorectal Cancer Risk

<table>Immunofluorescence staining of normal colorectal mucosa. Examples of immunofluorescence of normal colorectal mucosa labelled by DAPI (blue), CD2 (magenta, (a)-(b)), CD56 (red, (c)-(d)), and PLZF (green, (e)-(f)) in subjects with normal weight (BMI &lt; 25 Kg/m<sup>2</sup> and waist circumference &lt; 88 cm for women and &lt;102 cm for men; (a),(c), and (e)) and obese subjects (BMI &gt; 25 Kg/m<sup>2</sup> and waist circumference ≥ 88 cm for women and ≥102 cm for men; (b), (d), and (f)). Scale bar = 80 <i>μ</i>m.</table>

The Scientific World Journal

fig4

Figure 4

Figure 4: PLZF Expression during Colorectal Cancer Development and  in Normal Colorectal Mucosa according to Body Size, as Marker of Colorectal Cancer Risk 

Figure 4 | PLZF Expression during Colorectal Cancer Development and  in Normal Colorectal Mucosa according to Body Size, as Marker of Colorectal Cancer Risk 